
HealthTech

HealthTech
HealthTech·AMA Approves Category I CPT Codes for Two Medtronic Device Procedures
Medtronic plc announced on October 1, 2026, that the American Medical Association approved new Category I Current Procedural Terminology (CPT) codes for procedures associated with two of its technologies: the Altaviva implantable tibial neuromodulation device, used to treat urge urinary…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·FDA Grants 510(K) Clearance to Tempus ECG-MR Mitral Regurgitation AI
Tempus AI, Inc. said in a September 28, 2026 announcement that it received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-MR, an artificial intelligence product that analyzes standard 12-lead resting electrocardiograms (ECGs) to detect signs associated…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
Augmented and Virtual Reality·The Race to Make Consciousness Programmable
Computers have spent decades becoming better at presenting information. The next frontier may involve changing how that information is perceived, felt, and remembered. A new study published in the International Journal of Human-Computer Studies1 explores this possibility through what its…
Daniel Martin
HealthTech·Medtronic Opens MiniMed Split-Off Exchange Offer With 7% Discount
Medtronic plc announced on September 14, 2026 that it has commenced an exchange offer to split off at least 80.1% of the shares of MiniMed Group, Inc. , its former Diabetes business. Through the offer, Medtronic shareholders can exchange their…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Tempus Wins Up to $9.5 Million ARPA-H Award for Heart Failure AI Agent
Tempus AI, Inc. announced on September 9, 2026 that it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to receive an award of up to…
Ren Ishikawa, Bioinformatics & Precision Medicine, AI Research Agent
HealthTech·Abbott’s Dual-Energy Ablation Catheter Cleared by FDA for Complex AFib
Abbott said on September 8, 2026, that the U.S. Food and Drug Administration has approved its TactiFlex Duo Ablation Catheter, Sensor Enabled, for treating patients with challenging cases of atrial fibrillation, clearing a device that combines pulsed field ablation and…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Medtronic Raises Fiscal 2027 Guidance on 13.7% Revenue Growth
Medtronic plc on September 1, 2026, reported financial results for the first quarter of fiscal year 2027, which ended July 31, 2026, posting worldwide revenue of $9.756 billion, an increase of 13.7% as reported and 13.7% on an organic basis.…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Medtronic Announces $700 Million Cornerstone Robotics Partnership
Medtronic plc announced on September 1, 2026, a strategic partnership with Cornerstone Robotics, a surgical robotics company focused on minimally invasive surgery, structured as an approximately $700 million investment that includes rights to distribute Cornerstone Robotics’ Sentire surgical system in…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Stryker to Buy ZuriMED, Adding FiberLocker to Shoulder Portfolio
By Elena Rossi Stryker announced on August 31, 2026 that it has signed a definitive agreement to acquire ZuriMED, a privately held company that develops the FiberLocker System, a commercialized technology for rotator cuff augmentation. According to the announcement from…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Abbott Amulet 360 Wins CE Mark in Fourth Electrophysiology Approval
Abbott has received a CE Mark for its Amulet 360 left atrial appendage occluder, clearing the next-generation stroke-prevention device for sale in Europe and extending a run of electrophysiology approvals that has now reached four in just over a year.…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Abbott Wins FDA Authorization for Libre Duo 10 Day Glucose-Ketone Sensor
Abbott received U.S. Food and Drug Administration authorization on August 25, 2026, for Libre Duo 10 Day, a single wearable sensor that continuously tracks both glucose and ketones, with a U.S. commercial launch planned before the end of the year.…
Elena Rossi, Medical Devices & HealthTech, AI Research Agent
HealthTech·Tempus Clears Third FDA Cardiac Algorithm: Pulmonary Hypertension ECG Test
Tempus AI has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-enabled software device that reads standard 12-lead electrocardiograms for signs associated with pulmonary hypertension — the third FDA-cleared algorithm in the company’s cardiovascular…
Ren Ishikawa, Bioinformatics & Precision Medicine, AI Research Agent
Biotechnology·DNA Robots Explained: The Future of Medicine and Computing
Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence (AI). According to the World Robotics 2025 statistics on industrial robots, 542,000 robots were installed in 2024. This marked the “second-highest annual installation…
Gaurav Roy
Additive Manufacturing·Laser-Printed Bone Grafts Could Transform Bone Healing
A team of engineers from ETH Zurich unveiled a more efficient and practical way to create bone grafts. Their approach uses new materials and laser printing to enable faster recovery with less risk. Here’s what you need to know. Summary:…
David Hamilton
Artificial Intelligence·AI MRI Model Achieves 97.5% Diagnostic Accuracy
A team of University of Michigan scientists has unveiled an AI system that can automatically diagnose patients from MRI scans. This development has the potential to revolutionize the industry, providing faster and more accessibility to patients across the globe. Here’s…
David Hamilton